Pet Food and Nutrition

CBD+CBDA Formula Improves Mobility in Feline Study

A recent scientific investigation has confirmed the positive impact of a specialized cannabidiol (CBD) and cannabidiolic acid (CBDA) mixture on the physical well-being of cats facing challenges in movement. Published in a respected veterinary journal, this rigorous study by ElleVet Sciences provides strong evidence for the therapeutic potential of their unique hemp-derived formulation. The findings indicate a promising advancement in addressing a common issue among feline companions, offering a safe and effective option to enhance their quality of life.

The research involved a meticulously designed randomized, double-blinded, placebo-controlled crossover study where cats experiencing difficulties with mobility were administered either the CBD/CBDA paste or a placebo over a six-week period. The results, corroborated by both veterinary professionals and pet guardians, showed marked improvements in several key indicators of mobility. Cats receiving the active treatment exhibited enhanced gait, better ability to traverse stairs, increased ease in jumping, and a noticeable increase in playful activities. Crucially, comprehensive blood analyses performed after the intervention revealed no adverse safety concerns, underscoring the product's tolerability.

Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR, and chief veterinary medical officer at ElleVet, emphasized the substantial need for reliable long-term solutions for feline mobility. He underscored that the company's research and subsequent product development aim to bridge a significant gap in veterinary care, providing tangible benefits for pets. Haley Israelson, CEO of ElleVet Sciences, reiterated the company's commitment to a science-first approach in meeting the unique requirements of cats. She expressed enthusiasm for the study's publication, highlighting its role in broadening the array of supportive treatments available for felines, thereby enriching the lives of both cats and their human families.

The dedication to scientific rigor and innovation shown in this study paves the way for a future where pet well-being is continually elevated through evidence-based solutions. It reflects a compassionate understanding of animals' needs and a proactive effort to provide them with happier, more active lives, fostering a deeper bond between pets and their owners.

PhytoGaia to Research PetGaia's Impact on Canine Skin and Coat Health

PhytoGaia, a company specializing in pet supplements, has initiated an eight-week clinical investigation to explore the benefits of its PetGaia product on canine skin and coat vitality. This rigorous study, conducted in collaboration with a Malaysian contract research organization, aims to generate robust scientific data to support PetGaia's efficacy claims, providing valuable insights for pet food manufacturers and formulators.

The comprehensive study will meticulously assess various aspects of skin and coat health in companion dogs receiving oral supplementation of PetGaia. Key metrics include the evaluation of skin issues such as redness, dryness, itchiness, and the formation of lesions. Furthermore, researchers will analyze improvements in coat attributes like shine, softness, shedding, and overall smoothness, providing a holistic view of the product's impact.

PetGaia is a distinctive extract derived from palm fruit, rich in beneficial compounds such as tocotrienols, alpha-tocopherol, plant-based squalene, and phytosterols. The extraction process is notably environmentally friendly, employing non-chemical, non-solvent, and non-biodiesel methods, underscoring PhytoGaia's commitment to natural and sustainable solutions.

Dr. Ariati Aris, a scientific affairs specialist at PhytoGaia, emphasized the importance of this controlled study. She stated that the goal is to produce strong, evidence-based results concerning PetGaia's effects on canine skin. She highlighted that working with a reputable contract research organization ensures the scientific integrity of the trial, yielding findings that can confidently guide product development and substantiation of claims for formulators and manufacturers.

Prior research on rodents has demonstrated the protective effects of dietary tocotrienols against oxidative stress in the skin and their role in promoting hair follicle regeneration. Human studies have also indicated that oral tocotrienol supplementation can lead to improvements in hair density and scalp health, alongside a reduction in adverse reactions such as erythema, edema, itching, and blistering, when compared to control treatments.

Bryan See, PhytoGaia's vice president, shared his personal motivation for supporting this research. As a dog owner, he has observed firsthand the challenges of sensitive skin in his own pets, particularly his French Bulldog, who is prone to food sensitivities and coat problems. This personal connection drives his enthusiasm for the study, viewing PetGaia as a natural and scientifically supported approach to enhancing skin and coat health. He looks forward to the study's outcomes and how they will benefit both pets and the brands that incorporate PetGaia into their products.

This clinical trial represents a significant step forward in understanding the potential of natural ingredients to improve pet health, offering a promising solution for maintaining optimal skin and coat conditions in dogs.

See More

Insect Protein Company Faces Liquidation After Financial Setbacks

A French company focused on insect farming, which produced protein and fertilizer from mealworms, has been ordered into judicial liquidation by a commercial court. This decision comes after a hearing earlier in December, as reported by various news outlets, signaling the end of a significant endeavor in sustainable agriculture.

Management acknowledged the inability to raise sufficient funds for their continuation plan, despite possessing a robust technological foundation and a revamped business model. This insolvency led to a request for judicial safeguard proceedings in September 2024, followed by judicial reorganization in March 2025. However, the company could not provide the required financial assurances to the court within the extended observation period, ultimately leading to its current predicament.

The past few years have been particularly difficult for the company, characterized by financial instability. In 2023, the firm implemented staff reductions as part of a strategic shift to prioritize the pet food market over general animal feed. Despite having secured over $500 million in investments historically, the company struggled to attract additional capital needed to achieve profitability, highlighting the inherent challenges in scaling innovative sustainable ventures.

The journey of pioneering companies in emerging industries like insect agriculture underscores the complex interplay of innovation, market dynamics, and financial sustainability. While groundbreaking ideas and advanced technologies offer immense potential, securing consistent funding and navigating economic shifts are crucial for long-term success. This case serves as a poignant reminder that even with significant investment and strategic pivots, external financial pressures can ultimately determine the fate of promising enterprises, emphasizing the resilience and adaptability required to transform innovative concepts into enduring commercial realities.

See More